Title: Long-term Follow-up Results From The Phase 2 Multicenter Study Of Ublituximab (utx), A Novel Glycoengineered Anti-cd20 Mab, In Patients With Rms

被引：0
|
作者：
Fox, E. [1 ]
Shubin, R. [2 ]
Bass, A. [3 ]
Huang, D. [4 ]
Lovett-Racke, A. [5 ]
Weiss, M. S. [6 ]
Bosco, J. [6 ]
Power, S. [6 ]
Mok, K. [6 ]
Wray, S. [7 ]
机构：
[1] Cent Texas Neurol Consultants, Round Rock, TX USA
[2] Arcadia Neurol Ctr, Arcadia, CA USA
[3] Neurol Ctr San Antonio, San Antonio, TX USA
[4] Ctr Multiple Sclerosis, Westerville, OH USA
[5] Ohio State Univ, Columbus, OH 43210 USA
[6] TG Therapeut, New York, NY USA
[7] Hope Neurol, Knoxville, TN USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 1_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P075
引用
收藏
页码：51 / 51
页数：1
相关论文
共 50 条
  • [21] Ublituximab (TG-1101), a Novel Glycoengineered Anti-CD20 Monoclonal Antibody, in Combination with Ibrutinib Is Highly Active in Patients with Relapsed and/or Refractory CLL and MCL; Results of a Phase II Trial
    Sharman, Jeff P.
    Farber, Charles M.
    Mahadevan, Daruka
    Schreeder, Marshall T.
    Brooks, Heather D.
    Kolibaba, Kathryn S.
    Fanning, Suzanne R.
    Klein, Leonard M.
    Sportelli, Peter
    Miskin, Hari P.
    Weiss, Michael S.
    Greenwald, Daniel R.
    BLOOD, 2014, 124 (21)
  • [22] Treating patients with autoimmune pancreatitis: Results from a long-term follow-up study
    Kamisawa, T
    Yoshiike, M
    Egawa, N
    Nakajima, H
    Tsuruta, K
    Okamoto, A
    PANCREATOLOGY, 2005, 5 (2-3) : 234 - 238
  • [23] A phase I trial of ublituximab (TG-1101), a novel glycoengineered anti-CD20 monoclonal antibody (mAb) in B-cell non-Hodgkin lymphoma patients with prior exposure to rituximab.
    O'Connor, Owen A.
    Deng, Changchun
    Amengual, Jennifer Effie
    Khalil, Mazen Y.
    Schreeder, Marshall T.
    Mahadevan, Daruka
    Nikolinakos, Petros
    Sawas, Ahmed
    Zain, Jasmine M.
    Patterson, Molly
    Moon, Amber
    Pauli, Emily K.
    Cutter, Kathy
    Mackenzie, Michelle Ann
    Brotherton, Marnie
    Hodgson, Jamie
    Cooper, Christen N.
    Sportelli, Peter
    Miskin, Hari P.
    Farber, Charles Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [24] Ublituximab (TG-1101), a Novel Glycoengineered Anti-CD20 Monoclonal Antibody, in Combination with Ibrutinib Is Highly Active in Patients with Relapsed and/or Refractory Mantle Cell Lymphoma; Results of a Phase II Trial
    Kolibaba, Kathryn
    Burke, John M.
    Brooks, Heather D.
    Mahadevan, Daruka
    Melear, Jason
    Farber, Charles M.
    Fanning, Suzanne R.
    Schreeder, Marshall T.
    Boccia, Ralph V.
    Sportelli, Peter
    Miskin, Hari P.
    Weiss, Michael S.
    Sharman, Jeff P.
    BLOOD, 2015, 126 (23)
  • [25] FINAL RESULTS OF A MULTICENTER PHASE IB SINGLE AGENT STUDY WITH THE NOVEL ANTI-CD20 MONOCLONAL ANTIBODY UBLITUXIMAB (TG-1101) IN PATIENTS WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
    Cazin, B.
    Lepretre, S.
    Coiffier, B.
    Aurran, T.
    Cartron, G.
    Feugier, P.
    Brehar, O.
    Sadoun, A.
    Sportelli, P.
    Miskin, H.
    Ribrag, V.
    HAEMATOLOGICA, 2013, 98 : 47 - 47
  • [26] Evaluation of Long-Term Follow-Up Results of the Patients with Anti-HDV Positivity
    Ceylan, Bahadir
    Fincanci, Muzaffer
    Muderrisoglu, Cuneyt
    Soysal, Ferda
    Eren, Gulhan
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2007, 12 (02): : 95 - 102
  • [27] Rapid response to and long-term effectiveness of anti-CD20 antibody in conventional therapy resistant Graves' orbitopathy: A five-year follow-up study
    Erdei, Annamaria
    Paragh, Gyorgy
    Kovacs, Peter
    Karanyi, Zsolt
    Berenyi, Ervin
    Galuska, Laszlo
    Lenkey, Agota
    Szabados, Lajos
    Gyory, Ferenc
    Ujhelyi, Bernadett
    Berta, Andras
    Boda, Judit
    Berta, Eszter
    Bodor, Miklos
    Gazdag, Annamaria
    Nagy, Endre V.
    AUTOIMMUNITY, 2014, 47 (08) : 548 - 555
  • [28] Long-term results of laparoscopic myotomy: Follow-up study of fifty patients
    Berch, BR
    Nava, RD
    Torquati, A
    Sharp, KW
    Richards, WO
    GASTROENTEROLOGY, 2005, 128 (04) : A801 - A801
  • [29] Long-term course of patients in neurological rehabilitation Phase B. Results of the 6-year follow-up in a multicenter study
    Pohl, M.
    Berger, K.
    Ketter, G.
    Krusch, C.
    Pause, M.
    Puschendorf, W.
    Schaupp, M.
    Schleep, J.
    Spranger, M.
    Steube, D.
    Scheidtmann, K.
    Mehrholz, J.
    NERVENARZT, 2011, 82 (06): : 753 - +
  • [30] Resolution of epiphora with nasolacrimal stents:: Results of long-term follow-up in a multicenter prospective study
    Lanciego, C
    Toledano, N
    De Miguel, S
    Perea, M
    Padilla, M
    Rodriguez-Merlo, R
    Dávila, J
    Ibarburen, C
    Cano, C
    García, IR
    García, LG
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2003, 14 (11) : 1417 - 1425
12345